Menu
← Oncology Approval Tracker
FDA DECISION ·
Methylnaltrexone bromide injection (first generic)
methylnaltrexone bromide · Actavis
Open LinkedIn brief ↓1 min read · estimated
APPROVED USE
What FDA approved
The first generic of the referenced prefilled injections for opioid-induced constipation, including in adults with advanced illness or active cancer pain requiring increased opioid dosing for palliative care. The product also has a non-cancer indication.
LAMPGEN ANALYSIS
Why it matters
The decision adds a supportive-care option in a cancer pain setting as well as non-cancer use.
What research teams should watch
Record the opioid regimen and screen for known or suspected bowel obstruction before dispensing the appropriate syringe.
PRIMARY RECORDS